Proteon Therapeutics, Inc. (PRTO)

[Whalatane]

Jt ...well March is the month for final trial read out ...correct ...and alls quiet as we await judgement day .
Have you looked at RETA ...anything that successfully halts or reverses declining kidney function with a good safety profile is a big deal .
P3 data 2nd half 2019 . Wife is a PA in Renal .
Let me know if U chk it out
Kiwi
Citi update out

$RETA Citi $185 PT, says bardoxolone will go the distance in multiple phase 3 trials and provide nephrologists globally a long awaited novel therapy that will change the way multiple forms of kidney disease are managed today, bardo has profile of multi-B product